Resources

Low adoption of piped oxygen infrastructure in health facilities in low- and middle-income countries (LMIC) may be related to countries’ reliance on predominant, globally recognized standards. Many of these standards were not created with the operational limitations of those countries in mind, such as supplies, access to labor, and financial resources. National medical gas pipeline standards can be ambiguous or nonexistent in LMIC. PATH and Build Health International (BHI) investigated five innovative technical options spanning facility design, material, and component sourcing, and installation that could help alleviate barriers to install piping.The goal of this investigation is to prompt global discussion on increased adoption of high-quality medical gas pipeline systems, and address the unmet need for sustainable and uninterrupted lifesaving oxygen in LMIC.

The ORS and zinc: A policy and advocacy primer outlines the current global status of ORS and zinc uptake and key actions to increase their scale-up, as well as advocate and communicate about improving access and use.PATH, with funding from the United States Agency for International Development and the Bill and Melinda Gates Foundation, reviewed literature and existing data sources and carried out 37 key informant interviews with global- and country-level stakeholders from five countries: Burkina Faso, Ethiopia, Kenya, Nigeria, and Pakistan.The findings summarized in this primer include key actions to scaling ORS and zinc, strategies for successful implementation, and priority areas for investment to advance progress.

This slide deck, presented at the Developing Countries Vaccine Manufacturers Network International annual general meeting in October 2024, describes updated results from a study to assess the current and planned state of vaccine manufacturing in Africa and provides insights into what’s needed to develop a robust and sustainable vaccine manufacturing ecosystem.We surveyed African vaccine manufacturers to better understand their current manufacturing capacity and capabilities, the progress they’ve made since 2023, and their future outlooks. This information can help stakeholders and funders better coordinate and prioritize actions to build a successful African vaccine manufacturing ecosystem.

On 14 October, 2024, PATH co-hosted a forum to begin the conversation on financing the remaining gaps in access to medical oxygen. The event highlighted the critical role of sustained financing and donor commitments, following the launch of the oxygen investment case commissioned by the Global Oxygen Alliance (GO2AL) and the Lancet Global Health Commission Report on Oxygen Access—and ahead of upcoming funding rounds from international donors.

This high-level webinar was part of the VacciNations Campaign, bringing together policymakers, technical teams, key decision-makers and civil society organizations from the African region and beyond.It focused on immunization financing and accountability, and what is needed to ramp up efforts towards the 2030 Sustainable Development Goals (SDG) 3 targets. The presentations included findings from recent studies on immunization financing, and identified strategies to improve funding and accountability mechanisms to achieve the 2030 SDG 3 targets.